Noticias de Eulerpool Pacira Biosciences

Pacira Biosciences Noticias de Acciones

Pacira Biosciences es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Pacira Biosciences.

• 12 de junio ·

  SeekingAlpha
  Impax Small Cap Fund Q1 2025 Commentary
• 11 de junio ·

  Yahoo
  Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
• 5 de junio ·

  Yahoo
  Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 23 de mayo ·

  SeekingAlpha
  Vertex: Continuing To Dominate In CF, But What About Its Pain Pipeline?
• 15 de mayo ·

  Yahoo
  Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee
• 9 de mayo ·

  Yahoo
  Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates
• 9 de mayo ·

  Yahoo
  Pacira BioSciences Inc (PCRX) Q1 2025 Earnings Call Highlights: Strong EXPAREL Sales and ...
• 9 de mayo ·

  SeekingAlpha
  Pacira BioSciences, Inc. 2025 Q1 - Results - Earnings Call Presentation
• 8 de mayo ·

  Yahoo
  Pacira: Q1 Earnings Snapshot
• 6 de mayo ·

  Yahoo
  Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis